Recent immunotherapeutic approaches have evolved as powerful treatment options with
high anti-tumour responses involving the patient's own immune system. Passive …

Immunotherapy with checkpoint inhibitors has prompted a major change not only in cancer
treatment but also in medical imaging. In parallel with the implementation of new drugs …

Triple-negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer,
which is relatively resistant to anti-programmed cell death-1 (α-PD1) therapy, characterized …

Purpose This study aimed to evaluate the real-world efficacy of immune checkpoint
inhibitors (ICIs), and to identify clinicolaboratory factors to predict treatment outcomes in …

Aim/Introduction: Despite the spectacular success of immune checkpoint inhibitor therapy
(ICT) in patients with metastatic cancer, only a limited proportion of patients benefit from ICT …

Background To find semi-quantitative and quantitative Positron Emission
Tomography/Magnetic Resonance (PET/MR) imaging metrics of both tumor and non …

Evaluation of cancer therapy with imaging is crucial as a surrogate marker of effectiveness
and survival. The unique response patterns to therapy with immune-checkpoint inhibitors …

MRI is a widely available clinical tool for cancer diagnosis and treatment monitoring. MRI
provides excellent soft tissue imaging, using a wide range of contrast mechanisms, and can …

Purpose To investigate the prognostic value of [18F] FDG PET/CT as part of response
monitoring in metastatic melanoma patients treated with immune checkpoint inhibitors (ICIs) …

Dear Sir, We have read with great interest the manuscript “Assessing immune organs on
[18F]-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter …